Why is PPCB Up Today?

PPCB
$2.48
▲ +132.24% (+$3.28)
Last updated: Aug 27, 2026 5:08 PM ET
🚨

Extreme Volatility Warning +132%

This stock has surged 132% today - an extremely rare move. Such parabolic gains often see significant pullbacks. Exercise extreme caution with any new positions.

Historical moves this large: <0.1% of trading days
Risk Level: EXTREME

Overall Confidence: 60%

60% Confident

Based on news, social sentiment, options activity, and sector analysis

NEWS 60% Confidence
🎯 Breaking News Coverage
2 news articles published about PPCB in last 2 days. Top headline: Propanc Biopharma Reports PRP Preclinical Pancreatic Cancer Data Showing Over 90% Tumor Growth Inhibition

✅ Move Confirmation

HIGH VOLUME 22.6x average volume

ACCUMULATION - This move is backed by significant volume and appears sustainable.

Market Comparison

PPCB is significantly outperforming the market (+131.5% vs SPY)
S&P 500
SPY
+0.75%
Nasdaq 100
QQQ
+1.2%
PPCB
This Stock
+132.24%
vs S&P 500: +131.49%
vs Nasdaq: +131.04%

📊 What Happens Next?

Probability Analysis

55% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, PPCB is expected to trade between:
$2.41 - $2.56

Quick Trade Ideas

Options strategies to consider for PPCB's 132% move

📊

No Options Available

PPCB doesn't have listed options or options data is currently unavailable.

Try another stock in our Options Calculator →
Disclaimer: These are educational examples only, not investment advice. Options involve significant risk including total loss of premium. Prices shown are estimates and may differ from actual market prices. Always do your own research and consider your risk tolerance.

🔔 Get PPCB Alerts

We'll notify you when PPCB's trend changes or a new signal fires.

Last updated: Aug 27, 2026 5:08 PM (-243 minutes ago)
Data refreshes every 30 minutes during market hours

Frequently Asked Questions

Why is PPCB stock up today?

2 news articles published about PPCB in last 2 days. Top headline: Propanc Biopharma Reports PRP Preclinical Pancreatic Cancer Data Showing Over 90% Tumor Growth Inhibition

Is PPCB stock a buy or sell right now?

Based on current analysis, PPCB shows 60% confidence in today's move. Volume is high which supports the trend. View full buy/sell analysis →

What is the PPCB stock price target?

PPCB is currently trading at $2.48. Based on today's momentum, the expected short-term range is $2.41 - $2.56. See long-term price prediction →

Will PPCB stock continue rising?

Our analysis shows a 55% probability that PPCB's move continues in the next 1-3 days.

Is PPCB stock oversold or overbought?

PPCB's RSI (Relative Strength Index) is currently at 81.3. This indicates overbought conditions - the stock may be due for a pullback as buying pressure appears stretched.

What is the momentum for PPCB stock?

PPCB's 10-day momentum indicator is at 1.51. Positive momentum - the stock has mild upward pressure supporting the current trend.

Is PPCB outperforming or underperforming the market?

PPCB (+132.24%) is currently significantly outperforming the market (+131.5% vs SPY). Today, the S&P 500 (SPY) is up 0.75%, and Nasdaq (QQQ) is up 1.20%.

What does MACD indicate for PPCB?

PPCB's MACD (0.06) is currently above the signal line (-0.06), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 23.6) is moderate.

Is PPCB in an uptrend or downtrend?

Based on moving average analysis, PPCB is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $1.23, 50-day SMA: $1.4.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL